124 related articles for article (PubMed ID: 1932528)
1. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
[TBL] [Abstract][Full Text] [Related]
2. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
3. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
Almus FE; Rao LV; Rapaport SI
Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
[TBL] [Abstract][Full Text] [Related]
4. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
Warn-Cramer BJ; Almus FE; Rapaport SI
Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
[TBL] [Abstract][Full Text] [Related]
5. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
Nordfang O; Valentin S; Beck TC; Hedner U
Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
[TBL] [Abstract][Full Text] [Related]
7. Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI).
Hansen JB; Olsen JO; Osterud B
Thromb Haemost; 1990 Aug; 64(1):124-6. PubMed ID: 2274917
[TBL] [Abstract][Full Text] [Related]
8. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X.
Warr TA; Rao LV; Rapaport SI
Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494
[TBL] [Abstract][Full Text] [Related]
9. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
10. A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1.
Bendz B; Andersen TO; Sandset PM
Thromb Res; 2000 Mar; 97(6):463-72. PubMed ID: 10704656
[TBL] [Abstract][Full Text] [Related]
11. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition.
Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI
Thromb Haemost; 1988 Dec; 60(3):453-6. PubMed ID: 3238648
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery.
Carson SD; Haire WD; Broze GJ; Novotny WF; Pirrucello SJ; Duggan MJ
Thromb Haemost; 1991 Nov; 66(5):534-9. PubMed ID: 1803617
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
14. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
16. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
[TBL] [Abstract][Full Text] [Related]
17. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
Kondo S; Kisiel W
Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
[TBL] [Abstract][Full Text] [Related]
18. Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors.
Sandset PM; Høgevold HE; Lyberg T; Andersson TR; Abildgaard U
Thromb Haemost; 1989 Nov; 62(3):856-60. PubMed ID: 2595660
[TBL] [Abstract][Full Text] [Related]
19. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
Sandset PM; Abildgaard U
Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
[TBL] [Abstract][Full Text] [Related]
20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
